Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

20 Feb 2017 07:01

RNS Number : 2478X
Plant Health Care PLC
20 February 2017
 

PLANT HEALTH CARE PLC

Director / PDMR Shareholdings("Plant Health Care", "PHC" or the "Company")

 

Plant Health Care plc (AIM: PHC) was notified that on 16 February 2017, Christopher Richards, Executive Chairman and Interim CEO of the Company, purchased a total of 452,351 ordinary shares of 1 pence in the capital of the Company ("Ordinary Shares") at a price of 19 pence per Ordinary Share. Following the purchase, Christopher Richards, is beneficially interested in 1,228,675 Ordinary Shares, representing approximately 0.83 per cent. of the Company's issued share capital.

 

PHC was further notified that on 17 February 2017, Carolyn Richards, the spouse of Christopher Richards purchased a total of 74,938 Ordinary Shares in the capital of the Company at a price of 20 pence per Ordinary Share. Following the purchase, Carolyn Richards is beneficially interested in 94,762 Ordinary Shares, representing approximately 0.06 per cent. of the Company's issued share capital.

 

PHC was further notified that on 17 February 2017, William Lewis, Non-Executive Director of the Company, purchased a total of 185,500 Ordinary Shares in the capital of the Company at a price of 21 pence per Ordinary Share. Following the purchase, William Lewis, Non-Executive Director, is beneficially interested in 373,460 Ordinary Shares, representing approximately 0.25 per cent. of the Company's issued share capital.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Christopher Richards

Carolyn Richards

William Lewis

2.

Reason for the Notification

a)

Position/status

Executive Chairman

Spouse of Executive Chairman and Interim CEO

Non-Executive Director

b)

Initial notification/ Amendment

Initial notification

Initial notification

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

Plant Health Care plc

Plant Health Care plc

b)

LEI

Pending

Pending

Pending

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1p each

Ordinary shares of 1p each

Ordinary shares of 1p each

Identification code

GB00B01JC540

GB00B01JC540

GB00B01JC540

b)

Nature of the transaction

Purchase of ordinary shares

Purchase of ordinary shares

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price

Volume

Price

Volume

Price

Volume

£0.19

452,351

£0.20

74,938

£0.21

185,500

d)

Aggregated information:

·Aggregated volume

·Price

Single transaction as in 4c) above

 

 

Single transaction as in 4c) above

 

 

Single transaction as in 4c) above

 

 

e)

Date of the transaction

16 February 2017

17 February 2017

17 February 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

London Stock Exchange, AIM Market (XLON)

London Stock Exchange, AIM Market (XLON)

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

 

Enquiries:

 

Plant Health Care plc

 

Dr Chris Richards, Executive Chairman and Interim CEO

Tel: +44 (0) 18 3788 0083

Liberum Capital - Nomad and Broker

 

Clayton Bush / Chris Clarke

Tel: +44 (0) 20 3100 2000

Company website: www.planthealthcare.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFDEDUFWSEEE
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.